Microbot Accounts Payable vs Net Working Capital Analysis

MBOT Stock

USD 1.08 0.09 9.09%

Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Accounts Payable and its Net Working Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Accounts Payable vs Net Working Capital

Accounts Payable vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Accounts Payable account and Net Working Capital. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Microbot Medical's Accounts Payable and Net Working Capital is -0.22. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Accounts Payable and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Microbot Medical are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Accounts Payable i.e., Microbot Medical's Accounts Payable and Net Working Capital go up and down completely randomly.

Correlation Coefficient

-0.22

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Microbot Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Microbot Medical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Working Capital

Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Selling General Administrative is likely to drop 3,924 in 2024.

Microbot Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.56	0.32	0.58	0.63	0.67	-0.73	-0.6	0.01	0.9	0.73	0.53	0.97	-0.1	-0.43	0.7	0.54	0.64	0.69	0.97	0.57	0.34	0.36	0.34	0.01	-0.21
Short Long Term Debt Total	0.56		0.71	0.86	-0.17	0.94	-0.07	-0.75	-0.04	0.6	0.67	0.09	0.45	-0.01	-0.46	0.83	0.07	0.75	0.87	0.46	0.96	0.51	0.46	0.45	-0.4	-0.27
Other Current Liab	0.32	0.71		0.9	-0.48	0.75	0.33	-0.88	0.36	0.12	0.72	0.41	0.12	0.13	-0.42	0.8	-0.08	0.87	0.86	0.15	0.61	0.32	0.64	0.65	-0.21	-0.43
Total Current Liabilities	0.58	0.86	0.9		-0.2	0.87	0.0	-0.87	0.28	0.47	0.75	0.4	0.42	0.16	-0.38	0.84	0.21	0.86	0.93	0.45	0.8	0.38	0.56	0.56	-0.31	-0.42
Total Stockholder Equity	0.63	-0.17	-0.48	-0.2		-0.06	-0.92	0.19	-0.18	0.66	0.03	0.23	0.77	-0.16	0.04	-0.09	0.63	-0.14	-0.12	0.76	-0.1	0.01	-0.22	-0.24	0.25	0.15
Property Plant And Equipment Net	0.67	0.94	0.75	0.87	-0.06		-0.14	-0.85	0.13	0.63	0.82	0.33	0.54	-0.05	-0.55	0.89	0.1	0.86	0.92	0.54	0.86	0.63	0.62	0.61	-0.23	-0.22
Net Debt	-0.73	-0.07	0.33	0.0	-0.92	-0.14		-0.06	0.02	-0.84	-0.19	-0.33	-0.83	0.24	0.18	-0.09	-0.66	0.02	-0.07	-0.82	-0.12	-0.13	0.02	0.05	-0.04	-0.16
Retained Earnings	-0.6	-0.75	-0.88	-0.87	0.19	-0.85	-0.06		-0.25	-0.36	-0.91	-0.55	-0.42	-0.03	0.54	-0.95	0.01	-1.0	-0.96	-0.43	-0.68	-0.36	-0.76	-0.76	0.14	0.49
Accounts Payable	0.01	-0.04	0.36	0.28	-0.18	0.13	0.02	-0.25		-0.04	0.34	0.65	-0.1	0.11	-0.19	0.13	-0.08	0.24	0.19	-0.09	-0.07	0.2	0.56	0.58	0.05	0.05
Cash	0.9	0.6	0.12	0.47	0.66	0.63	-0.84	-0.36	-0.04		0.52	0.32	0.92	-0.19	-0.39	0.53	0.57	0.4	0.53	0.92	0.61	0.39	0.24	0.2	-0.18	-0.02
Non Current Assets Total	0.73	0.67	0.72	0.75	0.03	0.82	-0.19	-0.91	0.34	0.52		0.66	0.57	-0.03	-0.64	0.94	0.04	0.92	0.91	0.56	0.64	0.47	0.76	0.75	-0.03	-0.3
Non Currrent Assets Other	0.53	0.09	0.41	0.4	0.23	0.33	-0.33	-0.55	0.65	0.32	0.66		0.41	-0.23	-0.55	0.47	0.37	0.56	0.47	0.43	0.04	0.2	0.75	0.74	0.13	-0.11
Cash And Short Term Investments	0.97	0.45	0.12	0.42	0.77	0.54	-0.83	-0.42	-0.1	0.92	0.57	0.41		-0.13	-0.32	0.55	0.58	0.47	0.53	0.99	0.5	0.27	0.18	0.15	0.04	-0.14
Net Receivables	-0.1	-0.01	0.13	0.16	-0.16	-0.05	0.24	-0.03	0.11	-0.19	-0.03	-0.23	-0.13		0.61	-0.02	-0.2	0.02	0.02	-0.11	0.08	-0.07	-0.22	-0.16	0.02	-0.21
Common Stock Shares Outstanding	-0.43	-0.46	-0.42	-0.38	0.04	-0.55	0.18	0.54	-0.19	-0.39	-0.64	-0.55	-0.32	0.61		-0.64	-0.09	-0.54	-0.59	-0.3	-0.41	-0.51	-0.66	-0.6	-0.07	-0.2
Non Current Liabilities Total	0.7	0.83	0.8	0.84	-0.09	0.89	-0.09	-0.95	0.13	0.53	0.94	0.47	0.55	-0.02	-0.64		0.04	0.96	0.98	0.54	0.8	0.43	0.69	0.67	-0.16	-0.39
Other Current Assets	0.54	0.07	-0.08	0.21	0.63	0.1	-0.66	0.01	-0.08	0.57	0.04	0.37	0.58	-0.2	-0.09	0.04		0.02	0.11	0.64	0.07	-0.04	-0.05	-0.08	-0.14	-0.01
Other Stockholder Equity	0.64	0.75	0.87	0.86	-0.14	0.86	0.02	-1.0	0.24	0.4	0.92	0.56	0.47	0.02	-0.54	0.96	0.02		0.96	0.48	0.68	0.36	0.76	0.76	-0.13	-0.48
Total Liab	0.69	0.87	0.86	0.93	-0.12	0.92	-0.07	-0.96	0.19	0.53	0.91	0.47	0.53	0.02	-0.59	0.98	0.11	0.96		0.54	0.83	0.43	0.67	0.66	-0.22	-0.41
Total Current Assets	0.97	0.46	0.15	0.45	0.76	0.54	-0.82	-0.43	-0.09	0.92	0.56	0.43	0.99	-0.11	-0.3	0.54	0.64	0.48	0.54		0.48	0.26	0.19	0.16	0.02	-0.15
Short Term Debt	0.57	0.96	0.61	0.8	-0.1	0.86	-0.12	-0.68	-0.07	0.61	0.64	0.04	0.5	0.08	-0.41	0.8	0.07	0.68	0.83	0.48		0.48	0.36	0.34	-0.34	-0.24
Property Plant And Equipment Gross	0.34	0.51	0.32	0.38	0.01	0.63	-0.13	-0.36	0.2	0.39	0.47	0.2	0.27	-0.07	-0.51	0.43	-0.04	0.36	0.43	0.26	0.48		0.31	0.29	0.38	0.58
Common Stock Total Equity	0.36	0.46	0.64	0.56	-0.22	0.62	0.02	-0.76	0.56	0.24	0.76	0.75	0.18	-0.22	-0.66	0.69	-0.05	0.76	0.67	0.19	0.36	0.31		1.0	-0.23	-0.25
Common Stock	0.34	0.45	0.65	0.56	-0.24	0.61	0.05	-0.76	0.58	0.2	0.75	0.74	0.15	-0.16	-0.6	0.67	-0.08	0.76	0.66	0.16	0.34	0.29	1.0		-0.24	-0.29
Short Term Investments	0.01	-0.4	-0.21	-0.31	0.25	-0.23	-0.04	0.14	0.05	-0.18	-0.03	0.13	0.04	0.02	-0.07	-0.16	-0.14	-0.13	-0.22	0.02	-0.34	0.38	-0.23	-0.24		0.58
Current Deferred Revenue	-0.21	-0.27	-0.43	-0.42	0.15	-0.22	-0.16	0.49	0.05	-0.02	-0.3	-0.11	-0.14	-0.21	-0.2	-0.39	-0.01	-0.48	-0.41	-0.15	-0.24	0.58	-0.25	-0.29	0.58

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Other Current Liab	608K	(131K)	396K	1.7M	3.2M	2.6M
Total Current Liabilities	4.8M	1.3M	2.0M	2.1M	3.8M	4.8M
Total Stockholder Equity	31.5M	24.3M	14.4M	7.3M	4.5M	4.3M
Property Plant And Equipment Net	1.2M	1.0M	888K	723K	406K	385.7K
Net Debt	(27.9M)	(18.8M)	(12.8M)	(2.0M)	(2.3M)	(2.4M)
Retained Earnings	(35.1M)	(44.3M)	(55.6M)	(68.8M)	(79.5M)	(83.5M)
Accounts Payable	284K	275K	279K	116K	357K	489.2K
Cash	28.8M	19.7M	13.5M	2.4M	2.5M	2.4M
Non Current Assets Total	1.2M	1.0M	888K	723K	406.0K	385.7K
Non Currrent Assets Other	259K	962K	5.0K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	31.3M	24.6M	15.5M	8.2M	6.4M	6.1M
Net Receivables	101K	340K	174K	103K	1.3M	1.4M
Common Stock Shares Outstanding	4.3M	7.1M	7.1M	7.3M	10.2M	10.7M
Liabilities And Stockholders Equity	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Non Current Liabilities Total	760K	626K	402K	179K	40K	38K
Other Current Assets	7.2M	270K	387K	612K	152K	144.4K
Other Stockholder Equity	66.6M	68.5M	69.9M	76.0M	83.9M	88.1M
Total Liab	5.6M	2.0M	2.4M	2.2M	3.8M	3.6M
Total Current Assets	35.9M	25.3M	15.9M	8.8M	7.9M	7.5M
Property Plant And Equipment Gross	1.2M	251.0	1.2M	1.1M	899K	854.1K
Common Stock Total Equity	406K	31K	72K	72.0	64.8	61.56
Common Stock	406K	31K	72K	80K	118K	112.1K
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Retained Earnings Total Equity	(20.6M)	(27.9M)	(35.1M)	(44.3M)	(50.9M)	(53.5M)
Capital Surpluse	30.2M	32.5M	70.0M	68.5M	61.7M	58.6M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M

Pair Trading with Microbot Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbot Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Microbot Stock

0.79	DH	Definitive Healthcare	Pair Corr
0.76	DOCS	Doximity	Pair Corr
0.81	VEEV	Veeva Systems Class Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Microbot Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbot Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbot Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbot Medical to buy it.

The correlation of Microbot Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbot Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbot Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Microbot Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock:

How To Invest In Microbot

Details

Is Microbot Stock a good investment?

Details

What is Microbot Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Microbot Stock analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	CEOs Directory Screen CEOs from public companies around the world
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.05)

Return On Assets

(0.69)

Return On Equity

(1.82)

The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Microbot Accounts Payable vs Net Working Capital Analysis

Accounts Payable vs Net Working Capital

Accounts Payable vs Net Working Capital Correlation Analysis

Correlation Coefficient

Accounts Payable

Net Working Capital

Microbot Medical fundamental ratios Correlations

Microbot Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Microbot Medical fundamental ratios Accounts

Pair Trading with Microbot Medical

Moving together with Microbot Stock

Complementary Tools for Microbot Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Liab	+ 0.98	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Assets
Short Term Debt	+ 0.96	Short Long Term Debt Total

Other Stockholder Equity	- 1.0	Retained Earnings
Total Liab	- 0.96	Retained Earnings
Non Current Liabilities Total	- 0.95	Retained Earnings
Net Debt	- 0.92	Total Stockholder Equity
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.88	Other Current Liab